News

Deal Announcements

Ellipse Technologies Secures Third VC Round

Wednesday, August 3, 2011 5:29:00 AM PDT | VentureDeal Staff
   Irvine, California  --  Medical device company Ellipse Technologies has closed $17.6 million in series C venture capital investment, according to a company statement.

Ellipse is developing an implantable remote control device for the treatment of spinal and orthopedic damage.

Investors in the financing included HBM BioVentures, BioStar Funds, Wexford Capital and the MedFocus Fund.

The company said it would use the funding to initiate commercialization of its lead products.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1